Catalyst Pharmaceuticals
CPRX
#3987
Rank
A$4.35 B
Marketcap
A$35.42
Share price
1.95%
Change (1 day)
2.96%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.19 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's total liabilities are A$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalyst Pharmaceuticals - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.19 B64.87%
2023-12-31A$0.12 B9.21%
2022-12-31A$0.11 B158.83%
2021-12-31A$42.7 M44.29%
2020-12-31A$29.59 M-16.27%
2019-12-31A$35.34 M157.59%
2018-12-31A$13.72 M142.16%
2017-12-31A$5.66 M70.33%
2016-12-31A$3.32 M-47.6%
2015-12-31A$6.34 M-40.04%
2014-12-31A$10.58 M137.41%
2013-12-31A$4.46 M113.87%
2012-12-31A$2.08 M-14.08%
2011-12-31A$2.42 M685.86%
2010-12-31A$0.3 M-20.4%
2009-12-31A$0.38 M-81.41%
2008-12-31A$2.08 M410.98%
2007-12-31A$0.4 M-58.33%
2006-12-31A$0.98 M109.15%
2005-12-31A$0.46 M435.02%
2004-12-31A$0.08 M
2002-12-31A$0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioMarin Pharmaceutical
BMRN
A$2.34 B 1,086.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.27 B 1,554.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 86,335.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.40 B 103.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 87,931.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$49.55 B 24,959.19%๐Ÿ‡บ๐Ÿ‡ธ USA